Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Precision BioSciences, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Precision BioSciences, Inc. is a genome editing company developing therapeutic products and technologies based on its proprietary ARCUS platform. The company's ARCUS technology uses engineered nucleases to make precise edits to DNA for treating genetic disorders, cancer, and other diseases. Precision BioSciences has in vivo and ex vivo gene editing programs in development, as well as a food division focused on genome-edited agricultural products. The company is advancing multiple clinical-stage programs and research collaborations in human health applications.